Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Enanta Pharmaceuticals (ENTA) Shares Outstanding (Diluted Average): 2012-2025

Historic Shares Outstanding (Diluted Average) for Enanta Pharmaceuticals (ENTA) over the last 4 years, with Sep 2025 value amounting to $21,336.

  • Enanta Pharmaceuticals' Shares Outstanding (Diluted Average) rose 0.85% to $21,336 in Q3 2025 from the same period last year, while for Sep 2025 it was $21,336, marking a year-over-year increase of 0.85%. This contributed to the annual value of $21,336 for FY2025, which is 0.85% up from last year.
  • Latest data reveals that Enanta Pharmaceuticals reported Shares Outstanding (Diluted Average) of $21,336 as of Q3 2025, which was down 99.90% from $21.4 million recorded in Q2 2025.
  • In the past 5 years, Enanta Pharmaceuticals' Shares Outstanding (Diluted Average) registered a high of $21.4 million during Q2 2025, and its lowest value of $20,171 during Q3 2021.
  • In the last 3 years, Enanta Pharmaceuticals' Shares Outstanding (Diluted Average) had a median value of $21.1 million in 2023 and averaged $15.4 million.
  • Data for Enanta Pharmaceuticals' Shares Outstanding (Diluted Average) shows a peak YoY climbed of 2.36% (in 2023) over the last 5 years.
  • Quarterly analysis of 5 years shows Enanta Pharmaceuticals' Shares Outstanding (Diluted Average) stood at $20.4 million in 2021, then rose by 2.10% to $20.8 million in 2022, then increased by 1.31% to $21.1 million in 2023, then grew by 0.71% to $21.2 million in 2024, then increased by 0.85% to $21,336 in 2025.
  • Its Shares Outstanding (Diluted Average) was $21,336 in Q3 2025, compared to $21.4 million in Q2 2025 and $21.4 million in Q1 2025.